The Role of Electroconvulsive Therapy in the Treatment of Severe Bipolar Mixed State

Psychiatric Clinics of North America

Volumn 43, Issue 1, 2020, Pages 187-197

  Perugi, Giulio ^a,b   Medda, Pierpaolo ^a   Barbuti, Margherita ^a   Novi, Martina ^a   Tripodi, Beniamino ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Bipolar disorder; Electroconvulsive therapy; Mixed states

Indexed keywords

BIPOLAR DISORDER; DISEASE BURDEN; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; HUMAN; INCIDENCE; LONG TERM CARE; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; THERAPY EFFECT; MAJOR DEPRESSION; TREATMENT OUTCOME;

BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; ELECTROCONVULSIVE THERAPY; HUMANS; TREATMENT OUTCOME;

EID: 85076530616     PISSN: 0193953X     EISSN: 15583147     Source Type: Journal    
DOI: 10.1016/j.psc.2019.10.010     Document Type: Review

References (68)

1. Swann, A.C., Lafer, B., Perugi, G., et al. Bipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis. Am J Psychiatry 170:1 (2013), 31–42.
2. Medda, P., Mauri, M., Fratta, S., et al. Long-term naturalistic follow-up of patients with bipolar depression and mixed state treated with electroconvulsive therapy. J ECT 29:3 (2013), 179–188.
3. Swann, A.C., Bowden, C.L., Morris, D., et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry 54:1 (1997), 37–42.
4. Kruger, S., Trevor Young, L., Braunig, P., Pharmacotherapy of bipolar mixed states. Bipolar Disord 7:3 (2005), 205–215.
5. Ghaemi, S.N., Hsu, D.J., Soldani, F., et al. Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 5:6 (2003), 421–433.
6. Goldberg, J.F., Harrow, M., Whiteside, J.E., Risk for bipolar illness in patients initially hospitalized for unipolar depression. Am J Psychiatry 158:8 (2001), 1265–1270.
7. Post, R.M., Baldassano, C.F., Perlis, R.H., et al. Treatment of bipolar depression. CNS Spectr 8:12 (2003), 1–10 [quiz: 11].
8. Ahlfors, U.G., Baastrup, P.C., Dencker, S.J., et al. Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium. Acta Psychiatr Scand 64:3 (1981), 226–237.
9. Nelson, L.A., Swartz, C.M., Melancholic symptoms during concurrent olanzapine and fluoxetine. Ann Clin Psychiatry 12:3 (2000), 167–170.
10. Post, R.M., Ketter, T.A., Uhde, T., et al. Thirty years of clinical experience with carbamazepine in the treatment of bipolar illness: principles and practice. CNS Drugs 21:1 (2007), 47–71.
11. Calabrese, J.R., Rapport, D.J., Kimmel, S.E., et al. Rapid cycling bipolar disorder and its treatment with valproate. Can J Psychiatry 38:3 Suppl 2 (1993), S57–S61.
12. Post, R.M., Uhde, T.W., Roy-Byrne, P.P., et al. Correlates of antimanic response to carbamazepine. Psychiatry Res 21:1 (1987), 71–83.
13. Khazaal, Y., Tapparel, S., Chatton, A., et al. Quetiapine dosage in bipolar disorder episodes and mixed states. Prog Neuropsychopharmacol Biol Psychiatry 31:3 (2007), 727–730.
14. Shorter, E., The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand Suppl(433), 2007, 5–13.
15. Kraepelin, E., Manic-depressive illness and paranoia. 1921, E & S Livingstone, Edinburgh (United Kingdom).
16. Angst, J., Azorin, J.M., Bowden, C.L., et al. Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study. Arch Gen Psychiatry 68:8 (2011), 791–798.
17. Koukopoulos, A., Sani, G., DSM-5 criteria for depression with mixed features: a farewell to mixed depression. Acta Psychiatr Scand 129:1 (2014), 4–16.
18. Medda, P., Toni, C., Perugi, G., The mood-stabilizing effects of electroconvulsive therapy. J ECT 30:4 (2014), 275–282.
19. Perugi, G., Akiskal, H.S., Micheli, C., et al. Clinical characterization of depressive mixed state in bipolar-I patients: Pisa-San Diego collaboration. J Affect Disord 67:1–3 (2001), 105–114.
20. Loo, C., Katalinic, N., Mitchell, P.B., et al. Physical treatments for bipolar disorder: a review of electroconvulsive therapy, stereotactic surgery and other brain stimulation techniques. J Affect Disord 132:1–2 (2011), 1–13.
21. Stromgren, L.S., Electroconvulsive Therapy in Aarhus, Denmark, in 1984: Its Application in Nondepressive Disorders. Convuls Ther 4:4 (1988), 306–313.
22. Devanand, D.P., Polanco, P., Cruz, R., et al. The efficacy of ECT in mixed affective states. J ECT 16:1 (2000), 32–37.
23. Gruber, N.P., Dilsaver, S.C., Shoaib, A.M., et al. ECT in mixed affective states: a case series. J ECT 16:2 (2000), 183–188.
24. Ciapparelli, A., Dell'Osso, L., Tundo, A., et al. Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry 62:7 (2001), 552–555.
25. Medda, P., Perugi, G., Zanello, S., et al. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J ECT 26:2 (2010), 82–86.
26. Medda, P., Toni, C., Mariani, M.G., et al. Electroconvulsive therapy in 197 patients with a severe, drug-resistant bipolar mixed state: treatment outcome and predictors of response. J Clin Psychiatry 76:9 (2015), 1168–1173.
27. Palma, M., Ferreira, B., Borja-Santos, N., et al. Efficacy of Electroconvulsive Therapy in Bipolar Disorder with Mixed Features. Depress Res Treat, 2016, 2016, 8306071.
28. Fink, M., Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand Suppl(441), 2013, 1–47.
29. Moskowitz, A.K., "Scared stiff": catatonia as an evolutionary-based fear response. Psychol Rev 111:4 (2004), 984–1002.
30. Kruger, S., Cooke, R.G., Spegg, C.C., et al. Relevance of the catatonic syndrome to the mixed manic episode. J Affect Disord 74:3 (2003), 279–285.
31. Sienaert, P., Dhossche, D.M., Vancampfort, D., et al. A clinical review of the treatment of catatonia. Front Psychiatry, 5, 2014, 181.
32. Rohland, B.M., Carroll, B.T., Jacoby, R.G., ECT in the treatment of the catatonic syndrome. J Affect Disord 29:4 (1993), 255–261.
33. England, M.L., Ongur, D., Konopaske, G.T., et al. Catatonia in psychotic patients: clinical features and treatment response. J Neuropsychiatry Clin Neurosci 23:2 (2011), 223–226.
34. Raveendranathan, D., Narayanaswamy, J.C., Reddi, S.V., Response rate of catatonia to electroconvulsive therapy and its clinical correlates. Eur Arch Psychiatry Clin Neurosci 262:5 (2012), 425–430.
35. van Waarde, J.A., Tuerlings, J.H., Verwey, B., et al. Electroconvulsive therapy for catatonia: treatment characteristics and outcomes in 27 patients. J ECT 26:4 (2010), 248–252.
36. Yatham, L.N., Kennedy, S.H., Schaffer, A., et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord 11:3 (2009), 225–255.
37. Solomon, D.A., Keitner, G.I., Miller, I.W., et al. Course of illness and maintenance treatments for patients with bipolar disorder. J Clin Psychiatry 56:1 (1995), 5–13.
38. Judd, L.L., Akiskal, H.S., Schettler, P.J., et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59:6 (2002), 530–537.
39. Weinstock, L.M., Miller, I.W., Psychosocial predictors of mood symptoms 1 year after acute phase treatment of bipolar I disorder. Compr Psychiatry 51:5 (2010), 497–503.
40. Kingsbury, S.J., Yi, D., Simpson, G.M., Psychopharmacology: rational and irrational polypharmacy. Psychiatr Serv 52:8 (2001), 1033–1036.
41. Fraser, L.M., O'Carroll, R.E., Ebmeier, K.P., The effect of electroconvulsive therapy on autobiographical memory: a systematic review. J ECT 24:1 (2008), 10–17.
42. Sachs, G.S., Peters, A.T., Sylvia, L., et al. Polypharmacy and bipolar disorder: what's personality got to do with it?. Int J Neuropsychopharmacol 17:7 (2014), 1053–1061.
43. Bates, J.A., Whitehead, R., Bolge, S.C., et al. Correlates of medication adherence among patients with bipolar disorder: results of the bipolar evaluation of satisfaction and tolerability (BEST) study: a nationwide cross-sectional survey. Prim Care companion J Clin Psychiatry, 12(5), 2010.
44. ValentíM, B.A., García-Amador, M., Molina, O., et al. Electroconvulsive therapy in the treatment of mixed states in bipolar disorder. Eur Psychiatry 23 (2008), 53–56.
45. Kho, K.H., van Vreeswijk, M.F., Simpson, S., et al. A meta-analysis of electroconvulsive therapy efficacy in depression. J ECT 19:3 (2003), 139–147.
46. Kellner, C.H., Ahle, G.M., Geduldig, E.T., Electroconvulsive therapy for bipolar disorder: evidence supporting what clinicians have long known. J Clin Psychiatry 76:9 (2015), e1151–e1152.
47. UKECTReviewGroup, Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet 361:9360 (2003), 799–808.
48. Mukherjee, S., Sackeim, H.A., Schnur, D.B., Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience. Am J Psychiatry 151:2 (1994), 169–176.
49. American Psychiatric Association. The practice of electroconvulsive therapy: racommendations for treatment, training and privileging. 2nd edition, 2001, Americam Psichiatic Association, Washington, DC.
50. Nivoli, A.M., Colom, F., Murru, A., et al. New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord 129:1–3 (2011), 14–26.
51. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159:4 Suppl (2002), 1–50.
52. Grunze, H., Kasper, S., Goodwin, G., et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression. World J Biol Psychiatry 3:3 (2002), 115–124.
53. Grunze, H., Kasper, S., Goodwin, G., et al. The world federation of societies of biological psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part II: treatment of mania. World J Biol Psychiatry 4:1 (2003), 5–13.
54. Kusumakar, V., Yatham, L.N., Haslam, D.R., et al. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry 42:Suppl 2 (1997), 79S–86S.
55. Sachs, G.S., Printz, D.J., Kahn, D.A., et al. The Expert Consensus guideline series: medication treatment of bipolar disorder 2000. Postgrad Med(Spec No), 2000, 1–104.
56. Beale, M.D., Kellner, C.H., ECT in treatment algorithms: no need to save the best for last. J ECT 16:1 (2000), 1–2.
57. Perugi, G., Medda, P., Zanello, S., et al. Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimul 5:1 (2012), 18–24.
58. Kellner, C.H., Greenberg, R.M., Murrough, J.W., et al. ECT in treatment-resistant depression. Am J Psychiatry 169:12 (2012), 1238–1244.
59. Torring, N., Sanghani, S.N., Petrides, G., et al. The mortality rate of electroconvulsive therapy: a systematic review and pooled analysis. Acta Psychiatr Scand 135:5 (2017), 388–397.
60. Semkovska, M., McLoughlin, D.M., Retrograde autobiographical amnesia after electroconvulsive therapy: on the difficulty of finding the baby and clearing murky bathwater. J ECT 30:3 (2014), 187–188 [discussion: 189–90].
61. Semkovska, M., McLoughlin, D.M., Measuring retrograde autobiographical amnesia following electroconvulsive therapy: historical perspective and current issues. J ECT 29:2 (2013), 127–133.
62. Andrade, C., Gangadhar, B.N., Swaminath, G., et al. Mania as a side effect of electroconvulsive therapy. Convuls Ther 4:1 (1988), 81–83.
63. Lewis, D.A., Nasrallah, H.A., Mania associated with electroconvulsive therapy. J Clin Psychiatry 47:7 (1986), 366–367.
64. Goodwin, F.K., Jamison, K.R., Manic-depressive illness. 2007, Oxford University Press, New York, 284–285.
65. Sachs, G.S., Bipolar mood disorder: practical strategies for acute and maintenance phase treatment. J Clin Psychopharmacol 16:2 Suppl 1 (1996), 32S–47S.
66. Bowden, C.L., New concepts in mood stabilization: evidence for the effectiveness of valproate and lamotrigine. Neuropsychopharmacology 19:3 (1998), 194–199.
67. Ketter, T.A., Calabrese, J.R., Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature. J Clin Psychiatry 63:2 (2002), 146–151.
68. Calabrese, J.R., Rapport, D.J., Mood stabilizers and the evolution of maintenance study designs in bipolar I disorder. J Clin Psychiatry 60:Suppl 5 (1999), 5–13 [discussion: 14–5].